HSPA9 and cancer: This review describes the discovery and development of a small molecule investigational new drug, sulfur heteroarotinoid A2 (SHetA2, pronounces “Ess-Het-Aye-Two), which inhibits cancer development and growth through disruption of complexes formed between mortalin and other HSP70 proteins with their client proteins.